KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
79 hedge funds and large institutions have $249M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
47% less capital invested
Capital invested by funds: $472M → $249M (-$224M)
Holders
79
Holding in Top 10
5
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$1.97M | |
| 2 | +$421K | |
| 3 | +$360K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$237K |
| 5 |
Squarepoint
New York
|
+$153K |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$2.99M | |
| 3 | -$2.09M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.09M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$2.06M |